Mice With Dementia Regain Motor Function After Stem Cells Are Transplanted Into Their Brains
- Input
- 2026-11-18 19:40:43
- Updated
- 2026-11-18 19:40:43

[Financial News] Researchers in South Korea have succeeded in restoring impaired motor function by transplanting stem-cell-derived neural progenitor cells into the brains of mice with PD. The technology can address two key challenges in developing PD cell therapies at once: securing cells of uniform quality and validating their efficacy.
Hanyang University said on the 18th that a joint research team led by Professor Oh Yo-han of the Department of Biomedical Science at its Graduate School of Biomedical Engineering and Professor Lee Yeon-jong of Sungkyunkwan University School of Medicine had developed a new differentiation technology that enhances the characteristics of midbrain dopamine neurons damaged by PD.
The team transplanted neural progenitor cells produced with this technology into the brains of mice with PD and severe motor impairments. The transplanted cells survived in the brain and developed into the dopamine neuron lineage. The team confirmed that the mice's motor function improved four and eight weeks after transplantation.
PD is a degenerative neurological disease in which dopamine neurons in the brain, which control body movements, gradually disappear. Cell therapy that grows stem cells into neural progenitor cells and transplants them into patients' brains has recently advanced to the clinical trial stage. However, commercializing it as an actual treatment requires technology that can reliably produce cells with consistent characteristics of the original brain cells.
The team addressed this problem by precisely controlling the timing and duration of three biological signals involved in stem cells developing into brain neurons. By optimizing the timing of key signals compared with existing technologies, the team achieved a proportion of about 90% of cells with the characteristics of normal midbrain dopamine neural progenitor cells on day 16 of culture. In direct comparisons with a leading existing differentiation method published in 2021, the new method also showed higher expression levels of key genes. Once mature, the resulting neurons secreted dopamine and even generated spontaneous electrical signals.
The technology also opens up opportunities for new drug development. The team used it to differentiate stem cells derived from cells of patients with PD, then used light to induce abnormal protein aggregation in the brain, which is considered a major cause of PD. This reproduced the pathology in which only dopamine neurons were selectively lost. The technology will make it possible to accurately assess in the lab how well new drug candidates prevent neuronal damage.
Professor Oh Yo-han said, "We precisely controlled when brain-development signals act to strengthen the intrinsic characteristics of neural progenitor cells, and validated their potential use in both cell and mouse models that reflect actual protein aggregation." He added, "The technology will be widely used in research to uncover the causes of PD and develop new cell therapies and therapeutic candidates."
The research was conducted with support from the Ministry of Science and ICT, the Ministry of Health and Welfare, and the Ministry of Education. The findings were published in the online edition of the international journal Advanced Science.
[email protected] Kim Man-gi Reporter